Song M K, Rosenthal M J, Hong S, Harris D M, Hwang I, Yip I, Golub M S, Ament M E, Go V L
Department of Pediatrics, Center for Human Nutrition, UCLA School of Medicine, Los Angeles, CA 90095-1742, USA.
Metabolism. 2001 Jan;50(1):53-9. doi: 10.1053/meta.2001.19427.
Previous studies have already shown that prostate extract (PE) has antidiabetic activity when given to animals and humans. In this study, we explore whether this antidiabetic activity is related to the high concentrations of zinc, cyclo (his-pro) (CHP), and the prostaglandin precursor, arachidonic acid (AA), in prostate tissue. When streptozotocin-induced diabetic rats were given drinking water containing 10 mg/L zinc and 100 mg/L PE for 3 weeks, fasting blood glucose levels and glucose clearance rates, but not plasma insulin levels, were significantly lower than at pretreatment. In subsequent experiments, blood glucose levels in rats given PE for 3 weeks were significantly lower than in rats given distilled water or 10 mg/L zinc alone. However, in rats given 100 mg/L CHP with zinc, blood glucose levels were also lower than in rats given PE alone. Time-course studies in diabetic rats given drinking water containing 20 mg/L Zn, 20 mg/L L-histidine, and 10 mg/L CHP showed that blood glucose levels dropped 209 +/- 53 mg/dL in 1 day and stayed low for 2 weeks. When CHP was replaced with 100 mg AA/L, blood glucose levels dropped 230 +/- 64 mg/dL in 5 days, but returned to the original values 11 days later. Growth rate improved and water consumption decreased significantly in CHP- and AA-treated diabetic rats. High intake of L-histidine and testosterone increased blood glucose concentrations in diabetic rats. To determine optimal dosages of CHP and AA, we gave rats drinking water containing 10 mg/L Zn and 0.5 mg/L L-histidine with various concentrations of CHP or AA. The most effective doses for reducing blood glucose levels were 0.32 mg CHP/kg/day and 11 mg AA/kg/day. These data suggest that the active antidiabetic ingredients in the PE are CHP, zinc, and AA or its precursors.
先前的研究已经表明,给动物和人类服用前列腺提取物(PE)具有抗糖尿病活性。在本研究中,我们探究这种抗糖尿病活性是否与前列腺组织中高浓度的锌、环(组氨酸-脯氨酸)(CHP)以及前列腺素前体花生四烯酸(AA)有关。当给链脲佐菌素诱导的糖尿病大鼠饮用含有10mg/L锌和100mg/L PE的水3周时,空腹血糖水平和葡萄糖清除率显著低于预处理时,但血浆胰岛素水平无显著变化。在随后的实验中,服用PE 3周的大鼠血糖水平显著低于服用蒸馏水或仅服用10mg/L锌的大鼠。然而,服用100mg/L CHP和锌的大鼠血糖水平也低于仅服用PE的大鼠。对饮用含有20mg/L锌、20mg/L L-组氨酸和10mg/L CHP的水的糖尿病大鼠进行的时间进程研究表明,血糖水平在1天内下降了209±53mg/dL,并在2周内保持较低水平。当用100mg AA/L替代CHP时,血糖水平在5天内下降了230±64mg/dL,但11天后恢复到初始值。CHP和AA治疗的糖尿病大鼠生长速率提高,饮水量显著减少。高剂量摄入L-组氨酸和睾酮会使糖尿病大鼠血糖浓度升高。为了确定CHP和AA的最佳剂量,我们给大鼠饮用含有10mg/L锌和0.5mg/L L-组氨酸以及不同浓度CHP或AA的水。降低血糖水平最有效的剂量分别为0.32mg CHP/(kg·天)和11mg AA/(kg·天)。这些数据表明,PE中的活性抗糖尿病成分是CHP、锌以及AA或其前体。